WhatsApp scrambles to explain privacy policies after controversial new update

WhatsApp has attempted to clarify its privacy policies after an ongoing controversy about a new update. The outcry has led to public comment from people including Elon Musk and Edward Snowden, who have advised users to switch to competitors such as Signal instead. Now WhatsApp has looked to clarify that only specific information will be shared with Facebook and that the content of messages – which are encrypted and so can't be accessed anyway – will stay private. Read More...

Globe Newswire

Antibiotics Technologies and Markets, 2025

Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) — The “Antibiotics: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. The global market for antibiotics should grow from $44.4 billion in 2020 to reach $65.4 billion by 2025 at a compound annual growth rate (CAGR) of 8.1% during the period of 2020-2025. The report focuses on newer drugs and innovations in chemical compounds, vaccines and biologicals, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control approaches, strategies and products; drugs used for symptomatic treatment and not for the elimination of the virus from the host; and details on manufacturers and suppliers of non-branded generics. This report will also highlight the current and future market potentiality of antibiotics with detailed analysis of competitive environment between the companies. Drivers, restraints, opportunities, pricing analysis, impact of COVID-19, other infectious diseases and a regulatory scenario assessment will be covered in the current report. The report covers a market projection for 2025, and a market share for key players.The report segments the market for antibiotics based on product type, route of administration, application and geography. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA inhibitors and other inhibitors (RNA, Mycolic Acid, Folic Acid). Based on route of administration, the market is segmented into oral and topical. The market is also presented based on application type, which is further segmented into human and veterinary.By geography, the market has been segmented into the North America, Europe, Asia-Pacific, South America, and Middle East and Africa regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2025. The report includes: 28 data tables and 16 additional tablesComprehensive overview of the global market for antibiotics within the pharmaceutical industryAnalyses of the global market trends, with data corresponding to market size for 2018-2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025Latest information on market growth drivers and opportunities, industry supply chain structure, regulatory developments, technological advancements, and demographic shifts shaping the overall antibiotics marketplaceEvaluation of market growth during the forecast period, and deep dive of market share analysis data basis of product type, product, route of administration, end-user and geographical regionCountry specific data and analysis for the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South AfricaImpact of COVID-19 on the pharmaceutical market for antibiotics and an outlook of short-term vs. long-term impacts of COVID-19 pandemicIdentification of the companies best positioned to meet the global market demand for antibiotic drugs on the basis of their proprietary technologies, M&A deals, collaborations, JVs and other strategic alliancesDetailed company profiles of the major global corporations, including Abbott, F. Hoffmann-La Roche AG, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer and Sanofi Key Topics Covered: Chapter 1: Introduction Study Goals and ObjectivesReasons for Doing This StudyScope of ReportInformation SourcesMethodologyGeographic BreakdownAnalyst’s Credentials Chapter 2: Summary and Highlights Chapter 3: Market and Technology Background Overview of AntibioticsCommon Side Effects of AntibioticsClassification of AntibioticsCell Wall InhibitorsProtein InhibitorsDNA InhibitorsOther Antibiotic ClassesOverview of Gram-negative and Gram-positive BacteriaRoute of AdministrationTrends in the Market for AntibioticsFunding for New Antibiotic DevelopmentIncreasing Focus on Antibiotic Drug Development by Smaller Pharmaceutical FirmsGrowing Public-Private Partnerships Chapter 4: Market Dynamics Market DriversGrowth of the Global Pharmaceutical Market Driven by AntibioticsRise in Geriatric Population and Infection RateIncreasing Prevalence of Hospital-acquired InfectionsImproved Awareness about Diseases and their AntibioticsMarket RestraintsAntibiotic-resistant InfectionsGenericization of Antibiotics and DrugsDeclining Research and Development (R&D) InvestmentSide Effects of AntibioticsMarket OpportunitiesMarket Expansion into Emerging CountriesDevelopment of Novel Antibacterial Agents Chapter 5: Market Breakdown by Product Global Market for Antibiotics by ProductCell Wall InhibitorsProtein InhibitorsDNA InhibitorsOther Types of Inhibitors Chapter 6: Market Breakdown by Route of Administration Global Market for Antibiotics by Route of AdministrationOral AntibioticsTopical AntibioticsOther Routes of Administration Chapter 7: Market Breakdown by Region Chapter 8: Impact of COVID-19 on the Pharmaceutical Industry Short-term ImpactChange in DemandShift of Communication and Promotions to Remote InteractionsResearch and Development ChangesLong-term ImpactDelayed Approvals for Non-COVID-related Pharmaceutical ProductsSelf-sufficiency in Pharma IndustryPharmaceutical Industry Growth Slow-DownChanges in Consumption Trends in Health-related Products Chapter 9: Clinical Developments and Pipeline Products Respiratory Tract Infections Chapter 10: Value Chain Analysis China is a Becoming a Center of Microbial Threats Chapter 11: Regulatory Scenario FDA and International RegulationRecent Regulatory ReformsKetek Case Study Chapter 12: Competitive Landscape Global Company Market Share AnalysisMergers, Collaborations, Partnerships and Acquisitions Chapter 13: Company Profiles AbbottF. Hoffmann-La Roche AGGlaxosmithkline PlcJohnson & JohnsonMerck & Co., Inc.Mylan N.V.Pfizer Inc.Sanofi For more information about this report visit https://www.researchandmarkets.com/r/q3bmsf Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Read More